연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
3865. CGE25-110: Identification of an Elusive CBFA2T3-GLIS2 Fusion Variant in Acute Megakaryoblastic Leukemia by Whole Genome Sequencing
Lee Y, Yoon S, Lee J, Park HJ, Kim BK, Hong KT, Phi JH, Lee JW, Kim SH, Kim R, Kang HJ, Koh JY, Choi JY.
J Natl Compr Canc Netw.
2025 Mar 28;23(3.5):CGE25-110
Link
3864. Meat intake and breast cancer risk from the Health Examinees study
Hyobin Leea,b,1, Woo-Kyoung Shinc,1, Katherine De la Torrea,d, Sukhong Mina, Sung Hyun Youc, Wonshik Hane,f,g, Jung Eun Leeh, Daehee Kang
Clinical Nutrition 53 (2025) 109–118
Link
3863. Preoperative Breast MRI and Survival Outcomes in Women 50 Years or Younger with Breast Cancer
Heera Yoen, MD* 1 • Hee-Chul Shin, MD, PhD* 2 • Kyung-Hwak Yoon, MD 2 • Jeong Hun Oh, MD 2 • Jiwon Park, MS 3 •Yunhee Choi, PhD 3 • Wonshik Han, MD, PhD 4,5 • Nariya Cho, MD, PhD 1,6,7 • Woo Kyung Moon, MD, PhD 1,6,7 •Su Min Ha, MD, PhD** 1,6,7 • Hong-Kyu Kim, MD, PhD
Radiology 2025; 317(1):e25043
Link
3862. Novel Bone Scan Features for Predicting Prognosis in Men With Bone Metastatic Prostate Cancer: A Retrospective Study
Byung Woo Kim # 1 2, Jang Hee Han # 3 4, Sang Hyun Yoo 3, Minh-Tung Do 3 5, Minho Kang 3, Seung-Bo Lee 6, Dongkyu Oh 7 8, Gi Jeong Cheon 7 9 10 11, Ja Hyeon Ku 3 4, Cheol Kwak 3 4, Young-Gon Kim 1 12 13, Chang Wook Jeong 3 14
J Korean Med Sci. 2025 Aug 25;40(33):e206.
Link
3861. Discovery of (4-Phenyl-cyclohexyl)acetate-Derived Tyrosylprotein Sulfotransferase 2 (TPST2) Inhibitors with Potent Anti-Tumor Activity for Immuno-Oncology Applications
Soo Bin Park 1, Hyun Kim 2, Yumi Oh 3, Minwoo Jin 1 4, Myeonggil Jeon 1, Yunjae Kim 2, Taein Park 4 5, Jihyun Kim 1, Beomki Cho 2, Chaemin Noh 1 4, Jihyeok Cho 1, Je-Heon Lee 1, Chanyeong Jeong 2, Ji-Woo Mok 1, Soo Hyun Eom 1 4 5, Sung-Yup Cho 3 6 7, Hansoo Park 2 8, Yong-Chul Kim 1 9
J Med Chem. 2025 Nov 13;68(21):22401-22427.
Link
3860. Integrative multi-omics of matched primary and liver metastatic colorectal cancer organoids identifies putative molecular targets
Chae-Young Kim 1, Soon-Chan Kim 2, Rumi Shin 3, Min Jung Kim 4, Seung-Yong Jeong 4, Ji Won Park 5, Ja-Lok Ku 6
Transl Oncol. 2026 Jan:63:102592.
Link
3859. The fifth edition of the WHO classification of mature T cell, NK cell and stroma-derived neopla는
Ayoma D Attygalle 1, Kennosuke Karube 2, Yoon Kyung Jeon 3 4, Wah Cheuk 5, Govind Bhagat 6, John K C Chan 7, Kikkeri N Naresh 8
J Clin Pathol. 2025 Mar 19;78(4):217-232.
Link
3858. Generation of super-resolution images from barcode-based spatial transcriptomics by deep image prior
Jeongbin Park, Seungho Cook, Dongjoo Lee, Jinyeong Choi, Seongjin Yoo, Sungwoo Bae, Hyung-Jun Im, Daeseung Lee, Hongyoon Choi
Cell Rep Methods. 2025 Jan 27;5(1):100937
Link
3857. Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study
Bhave M, Jhaveri KL, Kaufman PA, Aftimos P, Lombard J, Giridhar KV, Im SA, Ma CX, Lee KT, Kim SB, Sohn J, Li Y, Yuen E, Estrem ST, Nguyen B, Makena MR, Ismail-Khan R, Beeram M
Breast cancer research [Epub ahead of print]
Link
3856. KEYLYNK-009: Pembrolizumab Plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer and Clinical Benefit From First-Line Pembrolizumab Plus Chemotherapy
Rugo HS, Cescon DW, Robson ME, Im SA, Dalenc F, Yañez Ruiz E, Reyes-Cosmelli F, Walshe JM, Im YH, Kulyk S, Dudnichenko O, Llinás-Quintero N, Saji S, Miyoshi Y, Bardia A, Harbeck N, Haiderali A, Fan L, Mejia JA, Karantza V, Llombart-Cussac A
Clinical cancer research [Epub ahead of print]
Link